{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:38:57Z","timestamp":1792633137047,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008666","name":"Marathon Foundation of Tv3","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008666","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.jad.2026.122578","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:44:57Z","timestamp":1790783097000},"page":"122578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Beyond symptom resolution: Clinical burden and immunometabolic correlates of functional remission after mania"],"prefix":"10.1016","volume":"416","author":[{"given":"Samuel","family":"Pampols-P\u00e9rez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J","family":"Portella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicent","family":"Llorca-Bof\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Palacios-Garr\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricard","family":"L\u00f3pez-Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Vieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Mur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2026.122578_bb0005","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013"},{"key":"10.1016\/j.jad.2026.122578_bb0010","first-page":"71","article-title":"Neuroinflammation in bipolar depression","volume":"11","author":"Benedetti","year":"2020","journal-title":"Front. Psychol."},{"key":"10.1016\/j.jad.2026.122578_bb0015","first-page":"730","article-title":"Neuroprogression and the mechanisms of change in major depressive disorder, bipolar disorder, and schizophrenia: the potential for biomarker and treatment development","volume":"35","author":"Berk","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jad.2026.122578_bb0020","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.neubiorev.2010.10.001","article-title":"Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors","volume":"35","author":"Berk","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jad.2026.122578_bb0025","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jad.2009.05.014","article-title":"Clinical and neurocognitive predictors of functional outcome in bipolar euthymic patients: a long-term follow-up study","volume":"121","author":"Bonn\u00edn","year":"2010","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.jad.2026.122578_bb7000","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/wps.20441","article-title":"Staging in bipolar disorder: from theoretical framework to clinical utility","volume":"16","author":"Berk","year":"2017","journal-title":"World Psychiatry"},{"key":"10.1016\/j.jad.2026.122578_bb0030","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jad.2014.02.034","article-title":"Verbal memory as a mediator in the relationship between subthreshold depressive symptoms and functional outcome in bipolar disorder","volume":"160","author":"Bonn\u00edn","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122578_bb0035","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.euroneuro.2024.10.008","article-title":"A meta-analysis of data-driven cognitive subgroups in bipolar disorder","volume":"90","author":"Bora","year":"2025","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.jad.2026.122578_bb0040","doi-asserted-by":"crossref","DOI":"10.1192\/j.eurpsy.2026.10174","article-title":"Complete blood count-based inflammatory ratios in people with bipolar disorder: a systematic review and meta-analysis of neutrophil-to-lymphocyte, monocyte-to-lymphocyte, and platelet-to-lymphocyte ratios","volume":"69","author":"Cavaleri","year":"2025","journal-title":"Eur. Psych."},{"key":"10.1016\/j.jad.2026.122578_bb0045","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/bdi.12775","article-title":"Functional outcome assessment in bipolar disorder: a systematic literature review","volume":"21","author":"Chen","year":"2019","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2026.122578_bb0050","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.3240","article-title":"Meta-analysis of peripheral mean platelet volume in patients with mental disorders: comparisons in depression, anxiety, bipolar disorder, and schizophrenia","volume":"13","author":"Chen","year":"2023","journal-title":"Brain Behav."},{"key":"10.1016\/j.jad.2026.122578_bb0055","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/s41537-023-00405-5","article-title":"Symptomatic, functional and quality of life measures of remission in 194 outpatients with schizophrenia followed naturalistically in a 6-month, non-interventional study of aripiprazole once-monthly","volume":"9","author":"Correll","year":"2023","journal-title":"Schizophrenia"},{"key":"10.1016\/j.jad.2026.122578_bb0060","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1177\/0706743716656607","article-title":"Meta-analysis of the interval between the onset and management of bipolar disorder","volume":"62","author":"Dagani","year":"2017","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.jad.2026.122578_bb0065","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jad.2021.07.062","article-title":"Duration of untreated illness and bipolar disorder: time for a new definition? Results from a cross-sectional study","volume":"294","author":"Dell\u2019Osso","year":"2021","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122578_bb0070","doi-asserted-by":"crossref","first-page":"851","DOI":"10.5114\/aoms.2016.58928","article-title":"Obesity and inflammation: the linking mechanism and the complications","volume":"13","author":"Ellulu","year":"2017","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.jad.2026.122578_bb0075","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S2215-0366(16)30370-4","article-title":"C-reactive protein concentrations across the mood spectrum in bipolar disorder: a systematic review and meta-analysis","volume":"3","author":"Fernandes","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jad.2026.122578_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2010.11.007","article-title":"A systematic review of the global distribution and availability of prevalence data for bipolar disorder","volume":"134","author":"Ferrari","year":"2011","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122578_bb0085","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/mp.2016.3","article-title":"A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression","volume":"21","author":"Goldsmith","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2026.122578_bb0090","first-page":"32","article-title":"Atherogenic index of plasma as a cardiovascular risk marker in manic, depressive, and euthymic stages of bipolar disorder","volume":"46","author":"Kalelioglu","year":"2018","journal-title":"Turk. J. Cardiol."},{"key":"10.1016\/j.jad.2026.122578_bb0095","first-page":"116","article-title":"Inflammatory ratios (NLR, PLR, SII, SIRI, PIV) in bipolar disorder: a systematic review and meta-analysis","volume":"299","author":"Karageorgiou","year":"2022","journal-title":"J. Affect. Disord."},{"issue":"10","key":"10.1016\/j.jad.2026.122578_bb0100","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1080\/03007995.2023.2260302","article-title":"Neutrophil\/high-density lipoprotein cholesterol (HDL), monocyte\/HDL and platelet\/HDL ratios are increased in acute mania as markers of inflammation, even after controlling for confounding factors","volume":"39","author":"Korkmaz","year":"2023","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.jad.2026.122578_bb0105","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jad.2023.07.079","article-title":"Thiol-disulphide homeostasis, ischemia-modified albumin, complete blood count-derived inflammatory markers and C-reactive protein from acute mania to early remission in bipolar disorder","volume":"339","author":"Korkmaz","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122578_bb0110","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.euroneuro.2024.08.004","article-title":"Immuno-psychiatry: dreams or reality?","volume":"89","author":"Leboyer","year":"2024","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2026.122578_bb0115","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.sjpmh.2026.02.006","article-title":"Blood-based immune biomarkers and functional outcomes in acute schizophrenia: a retrospective cohort study","volume":"19","author":"Llorca-Bof\u00ed","year":"2026","journal-title":"Spanish J. Psych. Ment. Health"},{"key":"10.1016\/j.jad.2026.122578_bb0120","doi-asserted-by":"crossref","DOI":"10.1111\/eip.70059","article-title":"Impact of duration of untreated bipolar disorder on clinical outcomes: a systematic review","volume":"19","author":"Mena","year":"2025","journal-title":"Early Interv. Psych."},{"key":"10.1016\/j.jad.2026.122578_bb0125","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.2147\/NDT.S112374","article-title":"Mean platelet volume in bipolar disorder: the search for an ideal biomarker","volume":"12","author":"Mert","year":"2016","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jad.2026.122578_bb0130","doi-asserted-by":"crossref","first-page":"e924","DOI":"10.4088\/JCP.16m10968","article-title":"The impact of obesity on cognitive functioning in euthymic bipolar patients: a cross-sectional and longitudinal study","volume":"78","author":"Mora","year":"2017","journal-title":"J. Clin. Psych."},{"key":"10.1016\/j.jad.2026.122578_bb0135","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jpsychires.2013.05.018","article-title":"Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis","volume":"47","author":"Munkholm","year":"2013","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2026.122578_bb0140","first-page":"199","article-title":"Evaluation of lipid-immune indices (NHR, MHR, AIP, PIV) in bipolar disorder: associations with disease course and manic episode remission","volume":"32","author":"Ozcan Tozoglu","year":"2025","journal-title":"Ann. Med. Res."},{"issue":"Suppl. 2","key":"10.1016\/j.jad.2026.122578_bb0145","first-page":"19","article-title":"Staging and neuroprogression in bipolar disorder: treatment implications","volume":"14","author":"Post","year":"2012","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2026.122578_bb0150","first-page":"105","article-title":"Cardiometabolic risk in bipolar disorder: a critical review","volume":"30","author":"Rosenblat","year":"2017","journal-title":"Curr. Opin. Psych."},{"key":"10.1016\/j.jad.2026.122578_bb0160","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/nri2956","article-title":"Platelets and the immune continuum","volume":"11","author":"Semple","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jad.2026.122578_bb0165","first-page":"950","article-title":"Neuroprogression as an illness trajectory in bipolar disorder: a selective review of the current literature","volume":"282","author":"Serafini","year":"2021","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122578_bb0170","first-page":"301","article-title":"Neuroprogression and bipolar disorder: a systematic review","volume":"143","author":"Serafini","year":"2021","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2026.122578_bb0175","first-page":"197","article-title":"Platelets and inflammation: a review of the evidence","volume":"21","author":"Snoep","year":"2010","journal-title":"Platelets"},{"key":"10.1016\/j.jad.2026.122578_bb0180","first-page":"2315","article-title":"Platelets: versatile effector cells in hemostasis, inflammation, and the vasculature","volume":"32","author":"Vieira-de-Abreu","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jad.2026.122578_bb0185","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1017\/S0033291724002149","article-title":"Neuroprogression happens","volume":"54","author":"Vieta","year":"2024","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2026.122578_bb0190","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/wps.20351","article-title":"Functional remediation: the pathway from remission to recovery in bipolar disorder","volume":"15","author":"Vieta","year":"2016","journal-title":"World Psychiatry"},{"key":"10.1016\/j.jad.2026.122578_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2024.107209","article-title":"Lymphocyte-derived and lipoprotein-derived inflammatory ratios as biomarkers in bipolar disorder type I: characteristics, predictive values, and influence of current psychopharmacological treatments","volume":"171","author":"Villegas Garc\u00eda","year":"2025","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jad.2026.122578_bb0200","article-title":"Systemic immune-inflammation index and systemic inflammatory response index are associated with short-term outcomes in patients with bipolar disorder","volume":"13","author":"Wei","year":"2022","journal-title":"Front. Psychol."},{"key":"10.1016\/j.jad.2026.122578_bb0205","volume":"13","author":"Wei","year":"2022","journal-title":"Front. Psychol."},{"key":"10.1016\/j.jad.2026.122578_bb0210","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/bdi.13435","article-title":"Early intervention, relapse prevention, and neuroprogression in bipolar disorder: the evidence matters","volume":"26","author":"Yatham","year":"2024","journal-title":"Bipolar Disord."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016503272601431X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016503272601431X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:44:02Z","timestamp":1792629842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016503272601431X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":42,"alternative-id":["S016503272601431X"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2026.122578","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond symptom resolution: Clinical burden and immunometabolic correlates of functional remission after mania","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2026.122578","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"122578"}}